Invited Faculty
  • Benjamin Fisher
    Univ. of Birmingham
  • Benjamin Fisher studied medicine at the United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals in London, obtaining a BSc (Hons) in Immunology in 1996 and his MBBS in 1999. He trained as a Rheumatologist in London with academic studies at the Kennedy Institute of Rheumatology, Imperial College London. Here he worked on clinical trials and completed an MD(Res) on antibodies to citrullinated alpha enolase peptides in rheumatoid arthritis. Following this he was appointed as a Walport Clinical Lecturer at Imperial College London. He joined the University of Birmingham as a Senior Clinical Lecturer in 2012 and was appointed Professor of Rheumatology in 2022. He has published research papers on Sjögren’s syndrome and inflammatory arthritis and has participated in many national and international collaborations.
    A key focus of Dr Fisher's current work is on clinical trials and outcome measures in inflammatory disease, especially Sjögren’s. He is interested in novel clinical trial design and is currently Chief Investigator for a basket trial with an early phase asset, utilizing tissue-based outcomes across three inflammatory diseases. He was co-Chief Investigator for a phase 2 platform clinical trial in COVID-19 (CATALYST). Prof Fisher heads a multidisciplinary Sjogren’s clinic and is Chief Investigator for the Optimising Assessments in Sjögren’s Syndrome (OASIS) cohort. He is a deputy clinical director at the Cancer Research UK clinical trials unit Birmingham, leading the Inflammation and Advanced and Cellular Therapies (I-ACT) team.
    Research & Clinical Focus


    Clinical Trials




  • Date Time Room Session Title Lecture Title
    May 19 15:30-16:00 Room Grand Ballroom 103 [International Symposium 5] Stratification of Patients with Primary Sjögren’s Syndrome Labial minor salivary gland biopsy